Cours suspendu

Communiqués Avadel Pharmaceuticals plc

Actions

AVDL

IE00BDGMC594

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 11/02/2026			Varia. 5j.	Varia. 1 janv.
21,64 ^USD	+0,05%		-.--%	+0,42%

01/05	Avadel Pharmaceuticals plc publie ses résultats pour l'exercice clos le 31 décembre 2025	CI
02/03	Monopar Therapeutics Inc. nomme Susan Rodriguez au poste de directrice commerciale et de la stratégie, à compter du 2 mars 2026	CI

Communiqués

11/02	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
10/02	Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing	AQ
10/02	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
09/02	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
06/02	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
05/02	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
04/02	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
03/02	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
02/02	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
30/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
29/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
28/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
27/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
26/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
23/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
22/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
21/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals PLC	EQ
19/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
16/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
15/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
15/01	Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc	EQ
14/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
14/01	Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc	EQ
13/01	Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc	EQ
12/01	Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes	AQ